NT Farma SRL
NT Farma reported total assets of 56,255 € at the end of the 2026 financial year (annual accounts filed with the NBB on 27 Oct 2026).
The score of NT Farma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -6 % Total assets +51 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NT Farma's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 27 Oct 2026
- Year ended 31 Mar 2025filed on 31 Oct 2025
- Year ended 31 Mar 2024filed on 31 Oct 2024
- Year ended 31 Mar 2023filed on 31 Oct 2023
NT Farma's financial analysis
- Solvency43.3%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NT Farma
NT Farma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0783.941.726
- VAT number
- BE0783941726
- Peppol
- Registered · 0208:0783941726 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Mar 2022
- Registered office
- 7700 Mouscron
- Latest accounts
- 2026 · filed on 27 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
NT Farma (SRL) has been based in Mouscron since 2022, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 23,868 € and equity of 24,368 €; its revenue is not published. Its solvency stands at 43.3%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to NT Farma
Companies in the same business, of comparable size and area, outside its group.
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- Itipharma Ghyselen Retail sale of pharmaceutical products Soignies · balance sheet 61,934 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
- MGS Pharma Retail sale of pharmaceutical products Stavelot · balance sheet 68,803 €
- Tilosa Retail sale of pharmaceutical products Lokeren · balance sheet 70,195 €
- Van Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
- Kato van Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
Frequently asked questions about NT Farma
What is the revenue of NT Farma?
NT Farma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of NT Farma?
In Belgium, the VAT number is the company number prefixed with BE: BE0783941726 for NT Farma, if the company is VAT-registered. Its company number (CBE) is 0783.941.726.
Where is the registered office of NT Farma?
According to the CBE register, the registered office of NT Farma is in 7700 Mouscron.
What is the equity of NT Farma?
At the close of the 2026 financial year, the equity of NT Farma amounts to 24,368 €, a solvency of 43.3% of total assets.
Who manages NT Farma?
The register lists 1 active mandates at NT Farma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NT Farma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →